Viridian Therapeutics
VRDN
VRDN
33 hedge funds and large institutions have $84.5M invested in Viridian Therapeutics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$11.4M | |
| 2 | +$9.67M | |
| 3 | +$7.58M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.12M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$5.01M |
Top Sellers
| 1 | -$2.33M | |
| 2 | -$670K | |
| 3 | -$512K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$502K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$226K |